Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,238 public trials 2,059 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management

NCT02199236

Conditions
Anus Diseases, Anus Neoplasms, Colorectal Neoplasms, +11 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Follow Up Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Follow Up Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent and Follow up) Commack, New York, United States
  • Memorial Sloan Kettering Westchester (Follow Up Only) Harrison, New York, United States
View Trial Details
Completed

Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)

NCT04456699

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Providence Saint Joseph Medical Center, Disney Family Cancer ( Site 1392) Burbank, California, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 1383) Fullerton, California, United States
  • UC Health Memorial Hospital ( Site 1401) Colorado Springs, Colorado, United States
  • Poudre Valley Health System ( Site 1402) Fort Collins, Colorado, United States
View all 129 locations
View Trial Details
Completed

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

NCT01436656

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +23 more
Locations
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 24 locations
View Trial Details
Completed

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

NCT03430843

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +17 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • Toledo Clinic Cancer Center Toledo, Ohio, United States
  • Imelda Ziekenhuis Bonheiden Bonheiden, Belgium
  • Cliniques Universitaires Saint Luc Brussels, Belgium
View all 104 locations
View Trial Details
Completed

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

NCT03427814

Conditions
Advanced or Inoperable Gastric Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Miami Cancer Institute Miami, Florida, United States
  • Scri Florida Cancer Specialist East West Palm Beach, Florida, United States
  • Goshen Center For Cancer Care Goshen, Indiana, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
View all 65 locations
View Trial Details

Related conditions